Search Orphan Drug Designations and Approvals
-
Generic Name: | amifampridine phosphate |
---|---|
Date Designated: | 03/03/2015 |
Orphan Designation: | Treatment of congenital myasthenic syndromes |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 03/14/2024 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Catalyst Pharmaceuticals (dba Catalyst Pharmaceutical Partner, Inc) Suite 1500 Coral Gables, Florida 33134 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-